INTEGRA LIFESCIENCES HOLDINGS CORP Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $20.14 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-10-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2016-10-28
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-09-30 was $20.14M.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-06-30 was $12.76M, a 6.11% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-03-31 was $11.65M, a 0.72% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2015-09-30 was -$31.88M, a 454.63% decline year-over-year.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2016-09-30 | $20.14M 10-Q · filed 2016-10-28 | $32.90M derived: sum of 2 quarters · filed 2016-10-28 | $46.32M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $12.76M 10-Q · filed 2016-07-28 | $26.17M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $11.65M 10-Q · filed 2016-04-27 | ||
| 2015-09-30 | -$31.88M 10-Q · filed 2016-10-28 | -$19.86M derived: sum of 2 quarters · filed 2016-10-28 | -$8.13M 10-Q · filed 2016-10-28 |
| 2015-06-30 | $12.02M 10-Q · filed 2016-07-28 | $23.75M 10-Q · filed 2016-07-28 | |
| 2015-03-31 | $11.73M 10-Q · filed 2016-04-27 | ||
| 2014-09-30 | $8.99M 10-Q · filed 2015-11-04 | $15.89M 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |